Opportunity ID: 54385

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CI10-1007ARRA10
Funding Opportunity Title: American Recovery and Reinvestment Act EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC) INFRASTRUCTURE AND INTEROPERABILITY SUPPORT FOR PUBLIC HEALTH LABORATORIES
Opportunity Category: Other
Opportunity Category Explanation: Recovery Act
Funding Instrument Type: Other
Category of Funding Activity: Recovery Act
Category Explanation:
Expected Number of Awards: 25
Assistance Listings: 93.729 — ARRA -Health Information Technology and Public Health
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: May 06, 2010
Last Updated Date: May 07, 2010
Original Closing Date for Applications: Jun 08, 2010
Current Closing Date for Applications: Jun 08, 2010
Archive Date: Jul 08, 2010
Estimated Total Program Funding: $5,000,000
Award Ceiling: $600,000
Award Floor: $100,000

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligibility for these awards is limited to current grantees under the ELC cooperative agreement program which include:
-50 States
-District of Columbia
-Commonwealth of Puerto Rico
-Republic of Palau
-Cities of Chicago, IL; Houston, TX; Los Angeles, CA; New York, NY; Philadelphia, PA

These 58 eligible applicants are currently funded under the following ELC Funding Opportunity Numbers:

CI04-040:

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) cooperative agreement is to assist state public health agencies in improving surveillance for, and response to, infectious diseases by (1) strengthening epidemiologic capacity; (2) enhancing laboratory capacity and practice; (3) improving information systems; and (4) developing and implementing prevention and control strategies. The focus of the activities is on naturally occurring infectious diseases and drug-resistant infections. ELC aims to enhance the ability of public health agencies to identify and monitor the occurrence of known infectious diseases of public health importance; detect new and emerging infectious disease threats, identify and respond to disease outbreaks; and use public health data for priority setting, policy development, and for prevention and control. Specifically within the Health Information Systems/National Electronic Disease Surveillance System (NEDSS) component of ELC, a key goal is to develop direct electronic data exchanges between sources of data (such as health care providers or laboratories – i.e., clinical care) and public health agencies.The purpose of this funding from the ARRA–HITECH Act is to support states through the ELC program to enhance and advance infrastructure and interoperability support for public health laboratories to satisfy Stage 1 Meaningful Use criteria as set out in the Centers for Medicare and Medicaid Services Meaningful Use Notice of Proposed Rule Making (published on January 13, 2010 in the Federal Register at edocket.access.gpo.gov/2010E9-31217.htm) for reporting to public health agencies using, when applicable, the HHS Standards & Certification Interim Final Rule: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology (available at edocket.access.gpo.gov/2010E9-31216.htm). These include the capability to provide electronic submission of reportable (as required by state or local law) lab results to public health agencies and actual submission where it can be received. See Appendix B for additional information on the Interim Final Rule and the Meaningful Use Notice of Proposed Rule Making.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDC

Procurement and Grants Office (PGO)

Technical Information Manageement Section (TIMS)

Phone 770-488-2700
Email:PGOTIM@cdc.gov

Version History

Version Modification Description Updated Date
No changes made. May 07, 2010
No changes made. May 07, 2010
May 07, 2010

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CI10-1007ARRA10
Funding Opportunity Title: American Recovery and Reinvestment Act EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC) INFRASTRUCTURE AND INTEROPERABILITY SUPPORT FOR PUBLIC HEALTH LABORATORIES
Opportunity Category: Other
Opportunity Category Explanation: Recovery Act
Funding Instrument Type: Other
Category of Funding Activity: Recovery Act
Category Explanation:
Expected Number of Awards: 25
Assistance Listings: 93.729 — ARRA -Health Information Technology and Public Health
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: May 06, 2010
Last Updated Date: May 07, 2010
Original Closing Date for Applications: Jun 08, 2010
Current Closing Date for Applications: Jun 08, 2010
Archive Date: Jul 08, 2010
Estimated Total Program Funding: $5,000,000
Award Ceiling: $600,000
Award Floor: $100,000

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligibility for these awards is limited to current grantees under the ELC cooperative agreement program which include:
-50 States
-District of Columbia
-Commonwealth of Puerto Rico
-Republic of Palau
-Cities of Chicago, IL; Houston, TX; Los Angeles, CA; New York, NY; Philadelphia, PA

These 58 eligible applicants are currently funded under the following ELC Funding Opportunity Numbers:

CI04-040:

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) cooperative agreement is to assist state public health agencies in improving surveillance for, and response to, infectious diseases by (1) strengthening epidemiologic capacity; (2) enhancing laboratory capacity and practice; (3) improving information systems; and (4) developing and implementing prevention and control strategies. The focus of the activities is on naturally occurring infectious diseases and drug-resistant infections. ELC aims to enhance the ability of public health agencies to identify and monitor the occurrence of known infectious diseases of public health importance; detect new and emerging infectious disease threats, identify and respond to disease outbreaks; and use public health data for priority setting, policy development, and for prevention and control. Specifically within the Health Information Systems/National Electronic Disease Surveillance System (NEDSS) component of ELC, a key goal is to develop direct electronic data exchanges between sources of data (such as health care providers or laboratories – i.e., clinical care) and public health agencies.The purpose of this funding from the ARRA–HITECH Act is to support states through the ELC program to enhance and advance infrastructure and interoperability support for public health laboratories to satisfy Stage 1 Meaningful Use criteria as set out in the Centers for Medicare and Medicaid Services Meaningful Use Notice of Proposed Rule Making (published on January 13, 2010 in the Federal Register at edocket.access.gpo.gov/2010E9-31217.htm) for reporting to public health agencies using, when applicable, the HHS Standards & Certification Interim Final Rule: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology (available at edocket.access.gpo.gov/2010E9-31216.htm). These include the capability to provide electronic submission of reportable (as required by state or local law) lab results to public health agencies and actual submission where it can be received. See Appendix B for additional information on the Interim Final Rule and the Meaningful Use Notice of Proposed Rule Making.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDC

Procurement and Grants Office (PGO)

Technical Information Manageement Section (TIMS)

Phone 770-488-2700
Email:PGOTIM@cdc.gov

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CI10-1007ARRA10
Funding Opportunity Title: American Recovery and Reinvestment Act EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC) INFRASTRUCTURE AND INTEROPERABILITY SUPPORT FOR PUBLIC HEALTH LABORATORIES
Opportunity Category: Other
Opportunity Category Explanation:
Funding Instrument Type: Other
Category of Funding Activity: Recovery Act
Category Explanation:
Expected Number of Awards: 25
Assistance Listings: 93.729 — ARRA -Health Information Technology and Public Health
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 07, 2010
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Jun 08, 2010
Archive Date: Jul 08, 2010
Estimated Total Program Funding: $5,000,000
Award Ceiling: $600,000
Award Floor: $100,000

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligibility for these awards is limited to current grantees under the ELC cooperative agreement program which include:
-50 States
-District of Columbia
-Commonwealth of Puerto Rico
-Republic of Palau
-Cities of Chicago, IL; Houston, TX; Los Angeles, CA; New York, NY; Philadelphia, PA

These 58 eligible applicants are currently funded under the following ELC Funding Opportunity Numbers:

CI04-040:

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) cooperative agreement is to assist state public health agencies in improving surveillance for, and response to, infectious diseases by (1) strengthening epidemiologic capacity; (2) enhancing laboratory capacity and practice; (3) improving information systems; and (4) developing and implementing prevention and control strategies. The focus of the activities is on naturally occurring infectious diseases and drug-resistant infections. ELC aims to enhance the ability of public health agencies to identify and monitor the occurrence of known infectious diseases of public health importance; detect new and emerging infectious disease threats, identify and respond to disease outbreaks; and use public health data for priority setting, policy development, and for prevention and control. Specifically within the Health Information Systems/National Electronic Disease Surveillance System (NEDSS) component of ELC, a key goal is to develop direct electronic data exchanges between sources of data (such as health care providers or laboratories – i.e., clinical care) and public health agencies.

The purpose of this funding from the ARRA–HITECH Act is to support states through the ELC program to enhance and advance infrastructure and interoperability support for public health laboratories to satisfy Stage 1 Meaningful Use criteria as set out in the Centers for Medicare and Medicaid Services Meaningful Use Notice of Proposed Rule Making (published on January 13, 2010 in the Federal Register at edocket.access.gpo.gov/2010E9-31217.htm) for reporting to public health agencies using, when applicable, the HHS Standards & Certification Interim Final Rule: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology (available at edocket.access.gpo.gov/2010E9-31216.htm). These include the capability to provide electronic submission of reportable (as required by state or local law) lab results to public health agencies and actual submission where it can be received. See Appendix B for additional information on the Interim Final Rule and the Meaningful Use Notice of Proposed Rule Making.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Centers for Disease Control and Prevention

Procurement and Grants Office

TIMS

Phone 770-488-2700
Email:PGOTIM@cdc.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-CI10-1007ARRA10
Funding Opportunity Title: American Recovery and Reinvestment Act EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC) INFRASTRUCTURE AND INTEROPERABILITY SUPPORT FOR PUBLIC HEALTH LABORATORIES
Opportunity Category: Other
Opportunity Category Explanation:
Funding Instrument Type: Other
Category of Funding Activity: Recovery Act
Category Explanation:
Expected Number of Awards: 25
Assistance Listings: 93.729 — ARRA -Health Information Technology and Public Health
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 07, 2010
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Jun 08, 2010
Archive Date: Jul 08, 2010
Estimated Total Program Funding: $5,000,000
Award Ceiling: $600,000
Award Floor: $100,000

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligibility for these awards is limited to current grantees under the ELC cooperative agreement program which include:
-50 States
-District of Columbia
-Commonwealth of Puerto Rico
-Republic of Palau
-Cities of Chicago, IL; Houston, TX; Los Angeles, CA; New York, NY; Philadelphia, PA

These 58 eligible applicants are currently funded under the following ELC Funding Opportunity Numbers:

CI04-040:

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: The purpose of the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) cooperative agreement is to assist state public health agencies in improving surveillance for, and response to, infectious diseases by (1) strengthening epidemiologic capacity; (2) enhancing laboratory capacity and practice; (3) improving information systems; and (4) developing and implementing prevention and control strategies. The focus of the activities is on naturally occurring infectious diseases and drug-resistant infections. ELC aims to enhance the ability of public health agencies to identify and monitor the occurrence of known infectious diseases of public health importance; detect new and emerging infectious disease threats, identify and respond to disease outbreaks; and use public health data for priority setting, policy development, and for prevention and control. Specifically within the Health Information Systems/National Electronic Disease Surveillance System (NEDSS) component of ELC, a key goal is to develop direct electronic data exchanges between sources of data (such as health care providers or laboratories – i.e., clinical care) and public health agencies.

The purpose of this funding from the ARRA–HITECH Act is to support states through the ELC program to enhance and advance infrastructure and interoperability support for public health laboratories to satisfy Stage 1 Meaningful Use criteria as set out in the Centers for Medicare and Medicaid Services Meaningful Use Notice of Proposed Rule Making (published on January 13, 2010 in the Federal Register at edocket.access.gpo.gov/2010E9-31217.htm) for reporting to public health agencies using, when applicable, the HHS Standards & Certification Interim Final Rule: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology (available at edocket.access.gpo.gov/2010E9-31216.htm). These include the capability to provide electronic submission of reportable (as required by state or local law) lab results to public health agencies and actual submission where it can be received. See Appendix B for additional information on the Interim Final Rule and the Meaningful Use Notice of Proposed Rule Making.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Centers for Disease Control and Prevention

Procurement and Grants Office

TIMS

Phone 770-488-2700
Email:PGOTIM@cdc.gov

Folder 54385 Full Announcement-1 -> cdc-rfa-ci10-1007arra10 final 05.06.10.pdf

Packages

Agency Contact Information: CDC
Procurement and Grants Office (PGO)
Technical Information Manageement Section (TIMS)
Phone 770-488-2700
Email: PGOTIM@cdc.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.729 NCPDCID-NR American Recovery and Reinvestment Act PKG00018551 May 06, 2010 Jun 08, 2010 View

Package 1

Mandatory forms

54385 SF424-2.0.pdf

54385 SF424A-1.0.pdf

54385 HHS_CheckList-1.1.pdf

54385 Project-1.1.pdf

54385 Budget-1.1.pdf

Optional forms

54385 Other-1.1.pdf

2025-07-11T12:30:42-05:00

Share This Post, Choose Your Platform!

About the Author: